Maria Bedoya-Toro Munera - Jan 4, 2024 Form 4 Insider Report for Dermata Therapeutics, Inc. (DRMA)

Role
SVP, Regulatory Affairs
Signature
/s/ Gerald T. Proehl, Attorney-in-Fact
Stock symbol
DRMA
Transactions as of
Jan 4, 2024
Transactions value $
$0
Form type
4
Date filed
1/5/2024, 09:00 PM
Previous filing
Jan 5, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DRMA Stock Option (right to buy) Award $0 +25K $0.00 25K Jan 4, 2024 Common Stock 25K $0.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the option will vest as to 25% upon the 12-month anniversary of the grant date, and will vest as to 75% in 36 equal monthly installments commencing on the 12-month anniversary of the grant date.